Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Senior Vice President, Devices | July 02, 2026 | July 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date July 02, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,126 |
Reported balance
After 2026-07-02 transaction · row 1
1 source rowRow 1 · 2026-07-02 · Tax withholding · Disposed 17,269 · Balance 54,126 F1: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2036-07-06 | Direct | 61,139 |
Reported balance
After 2026-07-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-06 · Grant · Acquired 29,442 · Balance 61,139 F2: The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person.
F2: The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2026 Filed Jul 8, 2026 02:02 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 29,442 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001437749-26-022967 · rdgdoc.xml · derivative · entry 2 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,139 Underlying: Common stock · 29,442 shares Expires 2036-07-06 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| July 02, 2026 Filed Jul 8, 2026 02:02 UTC | BioCardia, Inc. BCDA · Entity 7752 | Tax withholdingCommon Stock | 17,269 | $1.24 | $21,413.56 |
DisclosureSEC source: 0001437749-26-022967 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,126 F1 · shares: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. F1 · price: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:37 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 39,521 | $1.20 | $47,425.20 |
DisclosureSEC source: 0001437749-26-022363 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,395 F1 · shares: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026. F1 · price: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:54 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001437749-25-037473 · rdgdoc.xml · derivative · entry 3 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,697 Underlying: Common stock · 20,000 shares Expires 2035-12-08 F3 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:54 UTC | BioCardia, Inc. BCDA · Entity 7752 | Tax withholdingCommon Stock | 15,172 | $1.37 | $20,785.64 |
DisclosureSEC source: 0001437749-25-037473 · rdgdoc.xml · nonDerivative · entry 2 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,874 F2 · shares: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person. F2 · price: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:54 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 38,078 | $1.37 | $52,166.86 |
DisclosureSEC source: 0001437749-25-037473 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,046 F1 · shares: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025. F1 · price: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 19:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | SaleCommon Stock | 3,257 | $2.00 | $6,514.00 |
DisclosureSEC source: 0001437749-24-038363 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,968 F1 · shares: The reported sale transactions were effected for tax planning purposes. Read SEC document |
| October 11, 2024 Filed Oct 17, 2024 01:57 UTC | BioCardia, Inc. BCDA · Entity 7752 | Tax withholdingCommon Stock | 6,840 | $2.65 | $18,126.00 |
DisclosureSEC source: 0001437749-24-031413 · rdgdoc.xml · nonDerivative · entry 2 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,225 F2 · shares: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person. F2 · price: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on October 11, 2024 and does not represent a sale by the Reporting Person. Read SEC document |
| October 11, 2024 Filed Oct 17, 2024 01:57 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 15,808 | $2.65 | $41,891.20 |
DisclosureSEC source: 0001437749-24-031413 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,065 F1 · shares: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024. F1 · price: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on October 11, 2024. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 22:24 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 15,512 | $1.77 | $27,456.24 |
DisclosureSEC source: 0001437749-23-016523 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,857 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on May 18, 2023 and does not represent a sale by the Reporting Person. Read SEC document |
| May 18, 2023 Filed May 23, 2023 01:33 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 43,803 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-23-015518 · rdgdoc.xml · derivative · entry 2 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,803 Underlying: Common Stock · 43,803 shares Expires 2033-05-18 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| May 18, 2023 Filed May 23, 2023 01:33 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 40,490 | $1.70 | $68,833.00 |
DisclosureSEC source: 0001437749-23-015518 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,490 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023. Read SEC document |
| May 12, 2022 Filed May 19, 2022 00:03 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 12,358 | $1.32 | $16,312.56 |
DisclosureSEC source: 0001437749-22-012953 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,879 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on April 14, 2022 and does not represent a sale by the Reporting Person. Read SEC document |
| April 14, 2022 Filed Apr 19, 2022 01:16 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001437749-22-009164 · rdgdoc.xml · derivative · entry 2 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2032-04-14 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| April 14, 2022 Filed Apr 19, 2022 01:16 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 30,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-009164 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,237 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 22:15 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | Tax withholdingCommon Stock | 9,953 | $4.35 | $43,295.55 |
DisclosureSEC source: 0001437749-21-014632 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,082 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on April 21, 2021 and does not represent a sale by the Reporting Person. Read SEC document |
| April 21, 2021 Filed Apr 28, 2021 00:24 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 48,670 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001437749-21-009940 · rdgdoc.xml · derivative · entry 2 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,670 Underlying: Common Stock · 48,670 shares Expires 2031-04-21 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on May 21, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| April 21, 2021 Filed Apr 28, 2021 00:24 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantCommon Stock | 9,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-009940 · rdgdoc.xml · nonDerivative · entry 1 GILLIS EDWARD M · CIK 0001241359 · Senior Vice President, Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,953 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 21, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.